Suppr超能文献

SARS-CoV-2 刺突蛋白特异性 CD4+ T 细胞反应针对包括奥密克戎在内的关注变异株具有保守性。

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.

机构信息

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Infectious and Tropical Disease Unit, Careggi University Hospital, Florence, Italy.

出版信息

Front Immunol. 2022 Jan 26;13:801431. doi: 10.3389/fimmu.2022.801431. eCollection 2022.

Abstract

Although accumulating data have investigated the effect of SARS-CoV-2 mutations on antibody neutralizing activity, less is known about T cell immunity. In this work, we found that the ancestral (Wuhan strain) Spike protein can efficaciously reactivate CD4+ T cell memory in subjects with previous Alpha variant infection. This finding has practical implications, as in many countries only one vaccine dose is currently administered to individuals with previous COVID-19, independently of which SARS-CoV-2 variant was responsible of the infection. We also found that only a minority of Spike-specific CD4+ T cells targets regions mutated in Alpha, Beta and Delta variants, both after natural infection and vaccination. Finally, we found that the vast majority of Spike-specific CD4+ T cell memory response induced by natural infection or mRNA vaccination is conserved also against Omicron variant. This is of importance, as this newly emerged strain is responsible for a sudden rise in COVID-19 cases worldwide due to its increased transmissibility and ability to evade antibody neutralization. Collectively, these observations suggest that most of the memory CD4+ T cell response is conserved against SARS-CoV-2 variants of concern, providing an efficacious line of defense that can protect from the development of severe forms of COVID-19.

摘要

尽管越来越多的数据研究了 SARS-CoV-2 突变对抗体中和活性的影响,但对 T 细胞免疫的了解较少。在这项工作中,我们发现,以前的 Alpha 变体感染后,S 蛋白的祖先(武汉株)可以有效地重新激活 CD4+T 细胞记忆。这一发现具有实际意义,因为在许多国家,无论感染的 SARS-CoV-2 变体如何,目前仅向以前感染过 COVID-19 的个体接种一剂疫苗。我们还发现,只有少数 Spike 特异性 CD4+T 细胞针对 Alpha、Beta 和 Delta 变体中的突变区域,无论是在自然感染后还是在接种疫苗后。最后,我们发现,自然感染或 mRNA 疫苗诱导的 Spike 特异性 CD4+T 细胞记忆反应的绝大多数也能抵抗奥密克戎变体。这一点很重要,因为这种新出现的菌株由于其高传染性和逃避抗体中和的能力,导致全球 COVID-19 病例突然增加,是令人关注的病毒变体。总的来说,这些观察结果表明,大多数记忆性 CD4+T 细胞反应对 SARS-CoV-2 变体是保守的,提供了一种有效的防御线,可以预防 COVID-19 的严重形式的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8826050/6119c635b1a4/fimmu-13-801431-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验